$44.9 Million is the total value of Healthcare Value Capital, LLC's 22 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 111.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $4,847,000 | +66.4% | 75,000 | +50.0% | 10.80% | +10.0% |
| PFE | New | PFIZER INC | $3,623,000 | – | 100,000 | +100.0% | 8.07% | – |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $3,569,000 | -3.0% | 100,000 | 0.0% | 7.95% | -35.9% | |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $3,159,000 | +163.2% | 450,000 | +80.0% | 7.04% | +74.0% |
| VYNE | New | VYNE THERAPEUTICS INC | $2,738,000 | – | 400,000 | +100.0% | 6.10% | – |
| TYME | Sell | TYME TECHNOLOGIES INC | $2,670,000 | +0.6% | 1,500,000 | -31.0% | 5.95% | -33.5% |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $2,370,000 | – | 100,000 | +100.0% | 5.28% | – |
| SPXU | New | PROSHARES TRcall | $2,368,000 | – | 100,000 | +100.0% | 5.27% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $2,236,000 | – | 200,000 | +100.0% | 4.98% | – |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $2,167,000 | – | 155,555 | +100.0% | 4.83% | – |
| ATRS | ANTARES PHARMA INC | $2,055,000 | +3.0% | 500,000 | 0.0% | 4.58% | -31.9% | |
| ALKS | New | ALKERMES PLC | $1,868,000 | – | 100,000 | +100.0% | 4.16% | – |
| AMRN | AMARIN CORP PLCcall | $1,863,000 | +27.0% | 300,000 | 0.0% | 4.15% | -16.1% | |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $1,578,000 | – | 25,000 | +100.0% | 3.51% | – |
| MRK | New | MERCK & CO. INC | $1,542,000 | – | 20,000 | +100.0% | 3.43% | – |
| GNLN | GREENLANE HLDGS INCcl a | $1,326,000 | +33.9% | 250,000 | 0.0% | 2.95% | -11.5% | |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $1,299,000 | – | 100,000 | +100.0% | 2.89% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $1,243,000 | – | 25,000 | +100.0% | 2.77% | – |
| VIXY | Buy | PROSHARES TR IIcall | $935,000 | +36.1% | 100,000 | +100.0% | 2.08% | -10.1% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INCcall | $559,000 | – | 50,000 | +100.0% | 1.24% | – |
| ADMS | ADAMAS PHARMACEUTICALS INC | $480,000 | +10.9% | 100,000 | 0.0% | 1.07% | -26.7% | |
| GMDA | GAMIDA CELL LTD | $405,000 | -3.6% | 50,000 | 0.0% | 0.90% | -36.3% | |
| NVAX | Exit | NOVAVAX INCput | $0 | – | -5,000 | -100.0% | -1.88% | – |
| MRNA | Exit | MODERNA INCput | $0 | – | -10,000 | -100.0% | -3.52% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -25,000 | -100.0% | -4.51% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -10,000 | -100.0% | -5.56% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -10,000 | -100.0% | -5.86% | – |
| VYNE | Exit | VYNE THERAPEUTICS INC | $0 | – | -2,000,000 | -100.0% | -10.65% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -35,000 | -100.0% | -12.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.